✦ LIBER ✦

Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

✍ Scribed by Bester, A C; Schwartz, M; Schmidt, M; Garrigue, A; Hacein-Bey-Abina, S; Cavazzana-Calvo, M; Ben-Porat, N; Kalle, C Von; Fischer, A; Kerem, B

Book ID: 110039950
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 38 KB
Volume: 14
Category: Article
ISSN: 0969-7128
DOI: 10.1038/sj.gt.3302904

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fragile sites are preferential targets f

Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

✍ Bester, A C; Schwartz, M; Schmidt, M; Garrigue, A; Hacein-Bey-Abina, S; Cavazzan 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Common fragile sites are preferential ta

Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

✍ Thorland, Erik C; Myers, Shannon L; Gostout, Bobbie S; Smith, David I 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 319 KB

Integration profile of retroviral vector

Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell

✍ Luca Biasco; Alessandro Ambrosi; Danilo Pellin; Cynthia Bartholomae; Immacolata 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 893 KB

## Abstract The analysis of genomic distribution of retroviral vectors is a powerful tool to monitor ‘vector‐on‐host’ effects in gene therapy (GT) trials but also provides crucial information about ‘host‐on‐vector’ influences based on the target cell genetic and epigenetic state. We had the unique